MicrobeWorld App

appsquarebannerad200x200

Join MicrobeWorld

Subscribe via Email

subscribe

Microbes After Hours

MW-Site-Banner-200x200

Click for more "Microbes After Hours" videos

Featured Image

Featured Video

Crowdsourced Microbes Heading to Station

Supporters

ASM House 200X200

Dirt-Dwelling Bug Blocks Tuberculosis in African Vaccine Trial

An experimental vaccine based on a germ found in soil cut tuberculosis infections among people with HIV, the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations.

The shots reduced TB infections by 39 percent in patients who received them compared with those who got a placebo, according to a study published online by the journal AIDS today. The trial was stopped early, partly because of the clear effect of the vaccine, the study said.

Tuberculosis and HIV are a lethal combination, each speeding the other’s progress, according to the World Health Organization. The only existing TB vaccine -- the Bacillus Calmette-Guérin, or BCG, shot, which has been used to protect newborns since 1921 -- has “minimal or no protective effect” on adults, researchers led by Charles von Reyn at Dartmouth Medical School said in the study.
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use